Particle Therapy 2017

1616-1617 / 2605

QOL IN BRAIN SURVIVORS BY TUMOR-TYPE
DIFFERENCES BOTH THERAPEUTICAL GROUPS
• Intercomparison between outcome 2 oncological groups
with/without P+ access (MAS vs North CALIF)